Reaction Details Report a problem with these data
Target
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Ligand
BDBM8726
Substrate
n/a
Meas. Tech.
ChEMBL_877886 (CHEMBL2188143)
IC50
59±n/a nM
Citation
Gerusz, V; Denis, A; Faivre, F; Bonvin, Y; Oxoby, M; Briet, S; LeFralliec, G; Oliveira, C; Desroy, N; Raymond, C; Peltier, L; Moreau, F; Escaich, S; Vongsouthi, V; Floquet, S; Drocourt, E; Walton, A; Prouvensier, L; Saccomani, M; Durant, L; Genevard, JM; Sam-Sambo, V; Soulama-Mouze, C From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria. J Med Chem 55:9914-28 (2012) [PubMed] Article
More Info.:
Target
Name:
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Synonyms:
Enoyl-ACP Reductase (FabI) | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | FABI_STAAR | NADPH-dependent enoyl-ACP reductase | fabI | trans-2-enoyl-[acyl carrier protein] reductase
Type:
Enzyme
Mol. Mass.:
27989.00
Organism:
Staphylococcus aureus
Description:
Q6GI75
Residue:
256
Sequence:
MLNLENKTYVIMGIANKRSIAFGVAKVLDQLGAKLVFTYRKERSRKELEKLLEQLNQPEAHLYQIDVQSDEEVINGFEQIGKDVGNIDGVYHSIAFANMEDLRGRFSETSREGFLLAQDISSYSLTIVAHEAKKLMPEGGSIVATTYLGGEFAVQNYNVMGVAKASLEANVKYLALDLGPDNIRVNAISAGPIRTLSAKGVGGFNTILKEIEERAPLKRNVDQVEVGKTAAYLLSDLSSGVTGENIHVDSGFHAIK